"The compounding of knowledge leads to the compounding of wealth."

Shashank Mahajan

Founder, Value Educator

Browse by section

All articles

Pharma Stocks in India: Research and Analysis

India is one of the largest suppliers of generic medicines in the world. Its listed pharma companies sell branded medicines through doctors in India and emerging markets, generics in the US and Europe, store-brand medicines for pharmacy chains, drug ingredients (APIs) and contract manufacturing (CDMO) for global drug companies.

Our pharma research follows each company from its own filings: what it sells and where, how regulators have rated its plants, its latest results and margins, and the risks to its plans. The table below links every pharma company we have covered.

See all 13 companies and articles we have covered ↓
Results for “” 13 articles Clear search ×
Glenmark: India brands, US inhalers and cancer research
25 min read By Shashank Mahajan
Glenmark: The USD 700 Mn Cancer Deal and Its Brands
14th November, 2026 Read
Pharma stocks in India 2026: generics, APIs and CDMOs
8 min read By Shashank Mahajan
Pharma Stocks in India 2026: Generics, APIs and CDMOs
14th November, 2026 Read
Granules India: API powder, finished tablets and US pharmacy shelves
22 min read By Shashank Mahajan
Granules India: From Paracetamol to a 65% Gross Margin
14th November, 2026 Read
Natco Pharma: cancer medicines, US patent challenges and a South African stake
22 min read By Shashank Mahajan
Natco Pharma: After Revlimid, 29 Patent Challenges
14th November, 2026 Read
Shilpa Medicare: cancer APIs, biosimilars and oral films
22 min read By Shashank Mahajan
Shilpa Medicare: Cancer APIs, Films and Biosimilars
14th November, 2026 Read
Alembic Pharma: US generics, injectables and India brands
22 min read By Shashank Mahajan
Alembic Pharma: US Plants Pay Back, Margin Hits 22.2%
14th November, 2026 Read
Product Offerings
Call Our Experts Call Our Experts

Call Us

Articles Icon Articles

Articles